PGx Analysis in VarSeq: A User’s Perspective

varseq PGx Logo

About this webinar

June 19, 2024

Presented By: Darby Kammeraad, Director of Field Application Services & Solomon Reinman, Technical Field Application Scientist

Since our release of the PGx capabilities in VarSeq, we’ve had a few months to gather some insights from various use cases. Some users approach PGx workflows by means of array genotyping or what seems to be a growing trend of adding the star allele calling to the existing NGS pipeline for whole genome data. Luckily, both approaches are supported with the VarSeq software platform. The genotyping method being used will also dictate what the scope of the tertiary analysis will be. For example, are your PGx reports a standalone pipeline or would your lab’s goal be to handle a dual-purpose workflow and report on PGx + Diagnostic findings.

The purpose of this webcast is to:

  • Discuss and demonstrate the approaches with array and NGS genotyping methods for star allele calling to prep for downstream analysis.
  • Following genotyping, explore alternative tertiary workflow concepts in VarSeq to handle PGx reporting.

  • Moreover, we will include insights users will need to consider when validating their PGx workflow for all possible star alleles and options you have for automating your PGx analysis for large number of samples. Please join us for a session dedicated to the application of star allele genotyping and subsequent PGx workflows in our VarSeq software.

    Watch on demand

    Please enjoy this webcast recording. Should you have any questions about the content covered, please reach out to our team here.

    Download the slide deck

    To download a copy of the slides, visit our SlideShare page. From there, you can browse through our presentations and either clip your favorite slides or download the entire deck directly to your computer.

    Love this webcast? Check out more!

    Find out how Golden Helix software enables users to harness the full potential of genomics to identify the cause of disease, improve the efficacy and safety of drugs, develop genomic diagnostics, and advance the quest for personalized medicine.